Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-216755
Filing Date
2020-08-12
Accepted
2020-08-11 21:40:16
Documents
50
Period of Report
2020-06-28

Document Format Files

Seq Description Document Type Size
1 10-Q d48787d10q.htm   iXBRL 10-Q 811604
2 EX-31.1 d48787dex311.htm EX-31.1 6736
3 EX-31.2 d48787dex312.htm EX-31.2 6744
4 EX-32.1 d48787dex321.htm EX-32.1 3336
5 EX-32.2 d48787dex322.htm EX-32.2 3406
11 GRAPHIC g48787g85i86.jpg GRAPHIC 18356
  Complete submission text file 0001193125-20-216755.txt   3219391

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20200628.xsd EX-101.SCH 27322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001792044-20200628_cal.xml EX-101.CAL 21694
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001792044-20200628_def.xml EX-101.DEF 107582
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20200628_lab.xml EX-101.LAB 162518
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20200628_pre.xml EX-101.PRE 160105
12 EXTRACTED XBRL INSTANCE DOCUMENT d48787d10q_htm.xml XML 494007
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56114 | Film No.: 201093947
SIC: 2834 Pharmaceutical Preparations